ENMD 2076 |
ENMD-2076 |
FDA Approval | not approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
Drug Class | Kinase Inhibitors |
inhibitor (inhibitory) |
Novel drug target | Novel Target |
Trial Name | ENMD-2076 |
Mechanism of Interaction | Serine/threonine-protein kinase Aurora-A inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Fibroblast growth factor receptor 3 inhibitor |
Direct Interaction | yes |
Notes |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | ENMD-2076 |
Indication/Tumor Type | acute myeloid leukemia |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Macrophage colony stimulating factor receptor inhibitor |
Trial Name | ENMD-2076 |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | ENMD-2076 |
Novel drug target | Novel Target |
n/a |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Stem cell growth factor receptor inhibitor |
Novel drug target | Established target |
inhibitor (inhibitory) |
Notes | |
Direct Interaction | yes |
Mechanism of Interaction | Vascular endothelial growth factor receptor 2 inhibitor |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
n/a |
Novel drug target | Novel Target |
Trial Name | ENMD-2076 |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | ENMD-2076 |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
n/a |
Novel drug target | Established target |
Trial Name | ENMD-2076 |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Serine/threonine-protein kinase Aurora-B inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
inhibitor (inhibitory) |
n/a |
Trial Name | ENMD-2076 |
Novel drug target | Established target |
ENMD-2076 | Development Name |
Drug Class | Kinase Inhibitors |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | not approved |
ENMD-2076 | Primary Drug Name |
ENMD-2076 | Drug Synonym |
D0S7HM | TTD Drug ID |